KOC
ULBI icon

Koss-Olinger Consulting’s Ultralife ULBI Stock Holding History

Koss-Olinger Consulting’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,801
Closed -$105K – 257
2021
Q3 		$105K Hold
14,801
– – 0.02% 224
2021
Q2 		$124K Hold
14,801
– – 0.02% 237
2021
Q1 		$123K Buy
+14,801
New +$105K 0.02% 224

Other funds holding ULBI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
MPAM
Monarch Partners Asset Management Boston, Massachusetts $339M AUM 2.52% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Koss-Olinger Consulting's ULBI Position: Q4 2021 in Review

Koss-Olinger Consulting sold out of Ultralife (ULBI) in Q4 2021, closing a stake of 14,801 shares — an estimated $105K sold.

Koss-Olinger Consulting first reported a position in ULBI in Q1 2021 and held it in 3 quarters. The position peaked at $124K in Q2 2021. 32 funds tracked by Wall St. Rank hold ULBI as of Q4 2021.

  • Koss-Olinger Consulting reported no remaining Ultralife position as of Q4 2021 after selling out during the quarter.
  • Koss-Olinger Consulting sold 14,801 Ultralife shares in Q4 2021, an estimated $105K.
  • Koss-Olinger Consulting first reported a position in Ultralife in Q1 2021 and held it in 3 quarters.
  • Koss-Olinger Consulting's Ultralife position peaked at $124K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Ultralife as of Q4 2021.

Based on Koss-Olinger Consulting's 13F filing for Q4 2021, filed 7 Feb 2022.